Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
27,795,576
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
8,850,304
-
Shares change
-
+5,102,660
-
Total reported value, excl. options
-
$192,880,456
-
Value change
-
+$112,546,198
-
Put/Call ratio
-
141%
-
Number of buys
-
21
-
Number of sells
-
24
-
Price
-
$21.81
Institutional Holders of Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) as of Q1 2014
As of 31 Mar 2014 Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) had 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 8,850,304 shares of stock of the company.
Largest 10 holders included ORACLE INVESTMENT MANAGEMENT INC, FIRST REPUBLIC INVESTMENT MANAGEMENT, INC., Invesco Ltd., VANGUARD GROUP INC, BlackRock Fund Advisors, Wood Investment Counsel LLC, GOLDMAN SACHS GROUP INC, NORTHERN TRUST CORP, State Street Corp, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 65 institutional shareholders of the security as of 31 Mar 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.